Transfection technologies market to value $1.5 billion by 2026
Growth in the global transfection technologies market will be driven by emerging methods and the increasing prevalence of chronic diseases over the next five years.
List view / Grid view
Growth in the global transfection technologies market will be driven by emerging methods and the increasing prevalence of chronic diseases over the next five years.
New report suggests the cell line development services market will witness a 14.3 percent CAGR between 2021 and 2030.
The global polymerase chain reaction market is estimated to witness a compound annual growth rate CAGR of 9.91% during the forecast period 2017–2023...
19 July 2011 | By kdm communications limited
Sigma Life Science, announced the launch of CompoZr Targeted Integration Kit – mRosa26...
15 March 2011 | By kdm communications limited
To identify & validate targets for microRNA regulation...
2 September 2010 | By kdm communications limited
Sigma Life Science, today announced the global release of a pioneering range of engineered mammalian cell lines...